Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease

被引：0
|
作者：
Rita Khoury
机构：
[1] Department of Psychiatry and Clinical Psychology
[2] Saint George Hospital University Medical Center-Beirut
[3] Adjunct Faculty, Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine
来源：
Neural Regeneration Research | 2022年 / 05期
关键词：
D O I：
暂无
中图分类号：
R749.16 [];
学科分类号：
100203 ;
摘要：
Alzheimer’s disease(AD) is the most common type of neurode generative disorder; it affects around 47 million individuals worldwide(Prince et al., 2013). AD rose from the 12 th most burdensome disease in the United States in 1990 to the sixth in 2016 in terms of disability-adjusted life years(Alzheimer ’s Disease,
引用
收藏
页码：1013 / 1014
页数：2
相关论文
共 50 条
  • [31] Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
    Celina S. Liu
    Sarah A. Chau
    Myuri Ruthirakuhan
    Krista L. Lanctôt
    Nathan Herrmann
    [J]. CNS Drugs, 2015, 29 : 615 - 623
  • [32] Brexpiprazole in the treatment of schizophrenia and agitation in Alzheimer's disease
    Stummer, Lauren
    Markovic, Marija
    Maroney, Megan
    [J]. NEURODEGENERATIVE DISEASE MANAGEMENT, 2020, 10 (04) : 205 - 217
  • [33] Quetiapine in the treatment of agitation in patients with Alzheimer's disease
    Zhong, K
    Tariot, P
    Minkwitz, M
    Devine, N
    Mintzer, J
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 325 - 326
  • [34] An update on the advancements in the treatment of agitation in Alzheimer's disease
    Porsteinsson, Anton P.
    Antonsdottir, Inga M.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (06) : 611 - 620
  • [35] Prazosin for treatment of disruptive agitation in Alzheimer's disease
    Wang, Lucy Y.
    Petrie, Eric C.
    Rohde, Kirsten
    Hart, Kim L.
    Hoff, David J.
    Shofer, Jane B.
    Raskind, Murray A.
    Peskind, Elaine R.
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 200S - 200S
  • [36] Risk factors for agitation in patients with Alzheimer's disease
    Auchus, AP
    Woodard, JL
    Simpson, SR
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (09) : P192 - P192
  • [37] Therapeutic touch and agitation in individuals with Alzheimer's disease
    Hawranik, Pamela
    Johnston, Pat
    Deatrich, Judith
    [J]. WESTERN JOURNAL OF NURSING RESEARCH, 2008, 30 (04) : 417 - 434
  • [38] Clinical Pipelines for Alzheimer's Disease Psychosis and Agitation
    Oguma, Takuya
    Jino, Kohei
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2024, 72 (07) : 610 - 617
  • [39] Dextromethorphan/Quinidine: Safety, Tolerability, and Effectiveness for Pseudobulbar Affect in Patients with Alzheimer's Disease/Dementia: PRISM-II-Dementia-Cohort Results
    Doody, R. S.
    D'Amico, S.
    Cutler, A. J.
    Shin, P.
    Ledon, E.
    Yonan, C.
    Siffert, J.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S34 - S34
  • [40] Dextromethorphan/Quinidine In Pseudobulbar Affect
    Garnock-Jones, Karly P.
    [J]. CNS DRUGS, 2011, 25 (05) : 435 - 445
12345